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Abstract. Plerixafor (1,1'-[1,4-phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane) 
is an anticancer agent used to mobilize hematopoietic stem cells from the bone marrow to the 
bloodstream.1, 2  
Known synthetic strategies towards plerixafor include the protection of three nitrogen atoms of 
cyclam, further interaction with p-xylylene dihalides resulting in hexa-protected plerixafor derivatives, 
and removal of the protecting groups affording target drug3. The use of protecting groups combined with 
low total yields and scale-up issues increase the product cost. The high price of anticancer therapies 
involving plerixafor encourages the development of new methods simplifying drug preparation.  
To maximize the effectiveness of the synthesis, the protection/deprotection sequences should be 
avoided. Thus, we have suggested a novel method of plerixafor preparation based on the interaction of 
unprotected cyclam with para-substituted benzene derivatives 1 containing two electrophilic fragments 
(X, Y).  
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